CLCS

Cell Source, Inc. CLCS

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode CLCS FAMDF HMTXF TELIF MRES RVXCF CLYYF MDBIF ARUXF FNCH
6M 28.76 % -90.00 % 12.54 % 75.34 % -75.47 % 120.00 % -36.92 % 1 059.52 % -77.75 % -9.74 %
YTD 6.94 % -96.25 % -6.97 % 18.30 % -72.94 % 92.98 % 67.35 % 1 059.52 % -70.33 % 6.23 %
1Y 32.76 % -96.05 % 65.31 % 3.36 % 9.38 % 50.00 % 67.35 % 236.79 % -82.20 % 0.03 %
3Y 11 931.25 % -97.27 % -35.43 % 18.52 % -70.99 % -48.15 % 64.00 % -64.19 % -70.33 % -74.51 %
5Y -51.88 % -93.18 % 1 139.83 % -31.90 % -63.79 % -92.72 % -91.31 % -84.78 % -92.58 % -98.12 %
10Y -68.44 % -96.51 % 16 903.43 % -31.90 % -73.75 % -94.83 % -99.42 % -99.54 % -97.83 % -98.12 %
From the beginning -56.00 % -99.01 % 6 164.42 % -31.90 % -99.99 % -97.43 % -99.28 % -99.54 % -99.43 % -98.12 %

Dividend

Acrux Limited